期刊文献+

白细胞介素18、单纯疱疹病毒-胸苷激酶基因联合修饰骨髓间充质干细胞治疗脑胶质瘤 被引量:4

Interleukin-18-and HSV-tk-expressing bone marrow stromal cells exhibit antiglioma activity.
暂未订购
导出
摘要 目的了解骨髓间充质干细胞(bone marrow stromal cells,BMSCs)联合转染单纯疱疹病毒-胸苷激酶基因(HSV-tk)和白细胞介素18(interleukin-18,IL-18)后在荷瘤大鼠体内的治疗作用。方法提取1周龄大鼠骨髓培养大鼠骨髓间充质干细胞。骨髓间充质干细胞转染单纯疱疹病毒-胸苷激酶基因(BMSCs/tk)或白细胞介素18(BMSCs/IL-18)或联合转染单纯疱疹病毒-胸苷激酶基因、白细胞介素18(BMSCs/tk/IL-18),而后进行体内外试验检测其抗肿瘤作用。检测荷瘤鼠脾脏淋巴细胞免疫活性,采用TUNEL方法检测胶质瘤内的凋亡细胞,抗-CD34染色检测微血管密度(MVD),检测淋巴细胞的浸润,记录试验大鼠的生存期。结果骨髓间充质干细胞可稳定转染IL-18及tk基因,BMSCs/tk和BMSCs/IL-18/tk均显示了明显的旁观者效应,荷瘤鼠移植BMSCs/IL-18或BMSCs/IL-18/tk后,血清白细胞介素2和干扰素-γ浓度明显增高,并且接受移植的荷瘤鼠再次受到C6细胞冲击后可诱导快速的抗肿瘤免疫反应。微血管密度检测显示,BMSCs/IL-18(4.50±2.19)、BMSCs/tk/IL-18(3.65±2.13)与对照组(7.15±2.11)、PBS组(7.55±1.64)、BMSCs组(7.80±2.28)、BMSCs/tk组(7.65±1.84)比较有明显低的微血管密度(P<0.05),通过TUNEL检测、浸润淋巴细胞计数、细胞因子浓度及荷瘤鼠生存期比较,BMSCs/IL-18/tk比BMSCs/IL-18或BMSCs/tk显示了更加明显的抗肿瘤作用,BMSCs/IL-18/tk组生存期明显延长。结论联合转染单纯疱疹病毒-胸苷激酶基因和白细胞介素18的骨髓间充质干细胞显示了明显的抗恶性胶质瘤作用,骨髓间充质干细胞可能成为一种理想的治疗颅内胶质瘤的基因治疗载体。 Objective To investigate the effects of bone marrow stromal cells(BMSCs) co-transfected with IL-18-and HSV-TK on glioma-bearing rats.Methods BMSCs were isolated from one week old rats and were transfected with HSV-tk(BMSCs/tk) or rmIL-18(BMSCs/IL-18) or both HSV-tk and rmIL-18(BMSCs/tk/IL-18).Spleen lymphocyte was isolated to detect their immunity activity.TUNEL was used to identify apoptotic cells inside glioma.Anti-CD34,anti-CD8 and anti-CD4 staining was performed to evaluate microvessel density(MVD) and lymphocyte infiltration.The survival times of all rats were recorded.Results BMSCs co-transfected with IL-18 and HSV-tk could express IL-18 and HSV-tk stably.Both BMSCs/tk and BMSCs/IL-18/tk exhibited an obvious bystander effect.Transplantation with BMSCs/IL-18 or BMSCs/IL-18/tk increased the serum concentrations of IL-2 and IFN-γ in glioma-bearing rats and those rats exhibited a rapid immune response when rechallenged with C6 cells.The antiglioma activity of BMSCs/IL-18/tk was stronger compared with BMSCs/IL-18 or BMSCs/tk.The microvessel density was 7.15±2.11,,7.55±1.64,7.80±2.28 and 7.65±1.84,4.50±2.19 and 3.65±2.13 in control,PBS,BMSCs,BMSCs/tk,BMSCs/IL-18 and BMSCs/tk/IL-18 groups,respectively.The microvessel density was lower in BMSCs/IL-18 and BMSCs/tk/IL-18 groups.Conclusions BMSCs co-transfected with IL-18-and HSV-TK has a strong antiglioma activity and thus has a clinical implication in treatment of malignant gliomas.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2010年第6期325-330,共6页 Chinese Journal of Nervous and Mental Diseases
关键词 骨髓间充质干细胞 白细胞介素18 胶质瘤 单纯疱疹病毒-胸苷激酶基因 Bone marrow stromal cells Interleukin 18 Glioma HSV-tk
  • 相关文献

参考文献10

  • 1Maatta AM,Samaranayake H,Pikkarainen J,et al.Adenovirus mediated herpes simplex virus-thymidine kinase/ganciclovir gene therapy for resectable malignant glioma[J].Curr Gene Ther,2009,9(5):356-367.
  • 2Luo Y,Zhou H,Mizutani M,et al.A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence[J].Cancer Res,2005,65(8):3419-3427.
  • 3李春晖,焦保华,康春生,刘晓智.骨髓间充质干细胞向脑胶质瘤趋向性的初步研究(英文)[J].中国神经精神疾病杂志,2006,32(4):289-293. 被引量:10
  • 4李春晖,焦保华,史彦芳.转染白介素18的骨髓基质干细胞对脑荷瘤大鼠的免疫调节作用[J].中国免疫学杂志,2008,24(4):315-319. 被引量:6
  • 5Nico B,Benagiano V,Mangieri D,et al.Evaluation of microvascular density in tumors:pro and contra[J].Histol Histopathol,2008,23(5):601-607.
  • 6Ghochikyan A,Mkrtichyan M,Loukinov D,et al.Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen,brother of the regulator of imprinted sites[J].J Immunol,2007,178(1):566-573.
  • 7韩明勇,刘奇,彭佳平,郑树.白介素-18基因修饰SW480细胞肿瘤原性改变及抗瘤作用研究[J].中华肿瘤杂志,2007,29(2):105-106. 被引量:2
  • 8Xu G,Jiang XD,Xu Y,et al.Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats[J].Cell Biol Int,2009,33(4):466-474.
  • 9Subleski JJ,Wiltrout RH,Weiss JM.Application of tissue-specific NK and NKT cell activity for tumor immunotherapy[J].J Autoimmun,2009,33(3-4):275-281.
  • 10Müller-Hübenthal B,Azemar M,Lorenzen D,et al.Tumour Biology:tumour-associated inflammation versus antitumor immunity[J].Anticancer Res,2009,29(11):4795-4805.

二级参考文献17

  • 1Lee J,Kuroda S,Shichinohe H,et al.Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice.Neuropathology,2003,23 (3):169.
  • 2Nakamizo A,Marini F,Amano T,et al.Human bone marrow-de-rived mesenchymal stem cells in the treatment of gliomas.Cancer Res,2005,65 (8):3307.
  • 3Hamada H,Kobune M,Nakamura K,et al.Mesenchymal stem cells(MSC) as therapeutic cytoreagents for gene therapy.Cancer Sci,2005,96(3):149.
  • 4Borhane Annabi,Ying-Ta Lee,Sandra Turcotte,et al.Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation.Stem Cells,2003,21 (3),337.
  • 5Hwang KS, Cho WK, Yoo J, et al. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Cancer Gene Ther, 2004, 11:397-407.
  • 6Yamanaka R, Honma j, Tsuchiya N, et ai. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. J Neurooncol,2005, 72:107-113.
  • 7Jiang Y,Jahagirdar B N,Reinhardt R L et al.Huripotency of mesenchyreal stem cells derived from adult marrow[J]. Nature,2002,418:41-49.
  • 8Takahashi Y, Cleary K R, Mai M et al. Significance of Vesselcount and vascular endothehal growth factor and its receptor (KDR) in intestinal- type gastric cancer[J]. Cancer Res, 1996,2:1679-1684.
  • 9Nagai H, Hara I, Horikawa T et al. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tu- mor growth through inhibition of tumor vessel formation[ J]. J Invest Dermatol, 2002, 119: 541-548.
  • 10Tough D F, Zhang X, Sprent J. An IFN-gamma-dependent pathway controis stimulation of memory phenotype CD8^+ T cell turnover in vivo by IL- 12,IL-18,and IFN-gamma[J] .J Immunol,2001, 166:6007-6011.

共引文献15

同被引文献48

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部